Nucleotide Supplementation in Irritable Bowel Syndrome
Author Information
Author(s): C.P. Dancey, E.A. Attree, K.F. Brown
Primary Institution: University of East London, UK
Hypothesis
Symptoms of Irritable Bowel Syndrome would be improved with dietary nucleotide supplementation.
Conclusion
Dietary nucleotide supplementation improves some symptoms of irritable bowel syndrome above baseline and placebo levels.
Supporting Evidence
- Symptom severity for all symptoms except constipation improved from baseline to placebo to experimental condition.
- Abdominal pain and urgency to have a bowel movement showed the most significant improvement.
- Participants completed daily symptom diaries for four weeks before and during the trial.
Takeaway
This study tested a special supplement to see if it helps people with tummy troubles feel better, and it did help some of them a little bit.
Methodology
A double-blind randomised placebo cross-over study where participants rated symptoms daily for six months.
Potential Biases
Participants were not obtained from tertiary centers, which may limit generalizability.
Limitations
The improvements in symptoms were modest and the placebo effect was strong, making it difficult to detect the true effect of the supplement.
Participant Demographics
Participants were aged 18-65 with a diagnosis of IBS, primarily with diarrhoea as a main symptom.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% C.I.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website